Literature DB >> 7601440

Insertional mutation of the motor endplate disease (med) locus on mouse chromosome 15.

D C Kohrman1, N W Plummer, T Schuster, J M Jones, W Jang, D L Burgess, J Galt, B T Spear, M H Meisler.   

Abstract

Homozygous transgenic mice from line A4 have an early-onset progressive neuromuscular disorder characterized by paralysis of the rear limbs, muscle atrophy, and lethality by 4 weeks of age. The transgene insertion site was mapped to distal chromosome 15 close to the locus motor endplate disease (med). The sequence of mouse DNA flanking the insertion site junctions was determined. A small (< 20 kb) deletion was detected at the insertion site, with no evidence of additional rearrangement of the chromosomal DNA. Noncomplementation of the transgene-induced mutation and med was demonstrated in a cross with medJ/+mice. The new allele is designated medTgNA4Bs (medtg). The homologous human locus MED was assigned to chromosome 12. Synaptotagmin 1 and contactin 1 were eliminated as candidate genes for the med mutation. The transgene-induced allele provides molecular access to the med gene, whose function is required for synaptic transmission at the neuromuscular junction and long-term survival of cerebellar Purkinje cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7601440     DOI: 10.1016/0888-7543(95)80198-u

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

1.  Close linkage of three neuronal genes on distal mouse chromosome 15.

Authors:  J M Jones; B Ranscht; E O Berglund; S Gruenheid; P Gros; M H Meisler
Journal:  Mamm Genome       Date:  1996-09       Impact factor: 2.957

2.  Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons.

Authors:  Zoltán Ivics; Lajos Mátés; Tien Yin Yau; Vladimír Landa; Vaclav Zidek; Sanum Bashir; Orsolya I Hoffmann; László Hiripi; Wiebke Garrels; Wilfried A Kues; Zsuzsanna Bösze; Aron Geurts; Michal Pravenec; Thomas Rülicke; Zsuzsanna Izsvák
Journal:  Nat Protoc       Date:  2014-03-13       Impact factor: 13.491

3.  Evolution and divergence of sodium channel genes in vertebrates.

Authors:  G F Lopreato; Y Lu; A Southwell; N S Atkinson; D M Hillis; T P Wilcox; H H Zakon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Synaptotagmin genes on mouse chromosomes 1, 7, and 10 and human chromosome 19.

Authors:  J M Jones; S J Popma; M Mizuta; S Seino; M H Meisler
Journal:  Mamm Genome       Date:  1995-03       Impact factor: 2.957

Review 5.  Voltage-gated sodium currents in cerebellar Purkinje neurons: functional and molecular diversity.

Authors:  Joseph L Ransdell; Jeanne M Nerbonne
Journal:  Cell Mol Life Sci       Date:  2018-07-07       Impact factor: 9.261

6.  A missense mutation in the sodium channel Scn8a is responsible for cerebellar ataxia in the mouse mutant jolting.

Authors:  D C Kohrman; M R Smith; A L Goldin; J Harris; M H Meisler
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

7.  Preferential conduction block of myelinated axons by nitric oxide.

Authors:  Peter Shrager; Margaret Youngman
Journal:  J Neurosci Res       Date:  2016-09-10       Impact factor: 4.164

8.  Functional analysis of the mouse Scn8a sodium channel.

Authors:  M R Smith; R D Smith; N W Plummer; M H Meisler; A L Goldin
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

9.  The sodium channel Scn8a is the major contributor to the postnatal developmental increase of sodium current density in spinal motoneurons.

Authors:  K D García; L K Sprunger; M H Meisler; K G Beam
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

10.  Analysis of the mouse mutant Cloth-ears shows a role for the voltage-gated sodium channel Scn8a in peripheral neural hearing loss.

Authors:  F E Mackenzie; A Parker; N J Parkinson; P L Oliver; D Brooker; P Underhill; V A Lukashkina; A N Lukashkin; C Holmes; S D M Brown
Journal:  Genes Brain Behav       Date:  2009-06-22       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.